Atracurium Besylate

Known as: Atracurium dibesylate, Atracurium besilate, 1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium 
A synthetic dibenzensulfonate derivative muscle relaxant, Atracurium Besylate acts as a non-depolarizing neuromuscular blocking agent, with short to… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Glioblastoma multiforme (GBM) are the most common primary malignant brain tumor in adults, with a median survival of about one… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT 'Bepotastine besilate' is a novel second-generation antihistamine developed in Japan and… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Review
2001
Review
2001
Rapacuronium bromide (rapacuronium; ORG-9487) is a nondepolarising muscle relaxant (NMBA) with a low potency [90% effective dose… (More)
Is this relevant?
2001
2001
BACKGROUND AND OBJECTIVE To compare the effects on cardiovascular changes induced by tracheal intubation when small doses of… (More)
Is this relevant?
1995
1995
To ascertain the effects of chronic renal failure on the pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (a stereoisomer… (More)
  • table 1
  • figure 1
  • figure 2
  • table 3
  • table 4
Is this relevant?
1986
1986
Twenty-five patients with expansive pathologic brain lesions, who were anesthetized with thiopental, nitrous oxide in oxygen, and… (More)
Is this relevant?
1985
1985
The anaesthetic management of a young woman with dystrophia myotonica is described. The use of atracurium and monitoring of… (More)
Is this relevant?
1984
1984
The use of atracurium besylate, in small incremental doses, with continuous monitoring of neuromuscular function, is described… (More)
Is this relevant?
1983
1983
The plasma decay of atracurium besylate was examined in two groups of six patients. Group I received atracurium 0.6 mg kg-1 and… (More)
  • figure 1
  • table I
  • table III
  • figure 2
  • figure 3
Is this relevant?
1982
1982
Atracurium, a new non-depolarizing neuromuscular blocking agent, was studied in 70 patients anesthetized with fentanyl… (More)
Is this relevant?